Daily funding roundup - July 11th, 2019

Swit raised $6M; GetAccept landed $7M; DMC closed $10.3M; NEAR secured $12.1M

Swit: Swit is a collaboration suite that promises freedom from integrations. Swit has raised $6 million in seed funding. Korea Investment Partners led the round, with participation from Hyundai Venture Investment Corporation and Mirae Asset Venture Investment. Read more

SynergySuite: SynergySuite is an international provider of award-winning, cloud-based enterprise back-office software to leading global restaurant chains. SynergySuite has raised $6 million in Series A funding led by First Analysis, with participation from Oyster Capital. Read more

GetAccept: GetAccept is an AI-based eSignature & document tracking platform. GetAccept has raised $7 million in Series A funding. DN Capital led the round, joined by BootstrapLabs, Y Combinator, and some of Spotify’s early investors. Read more

Vyopta: Vyopta makes monitoring and analytics software for improving workplace collaboration, has raised $7.5 million in Series B funding from Elsewhere Partners. Read more

DMC: DMC is unleashing the manufacturing power of biology. DMC has raised $10.3 million in Series A funding led by Sofinnova Partners. Read more 

Vasopharm: Vasopharm is focused on the R&D of novel therapeutics for the treatment of cerebro and cardiovascular diseases and their symptoms. Vasopharm has raised €9.5 million. Heidelberg Capital and EF Investors co-led the round, joined by Creator Ventures and earlier investors Bayern Kapital, Future Capital, clients of Hanseatic Asset Management and Ringtons Holdings. Read more

Near Protocol: NEAR is a blockchain protocol designed to bridge the adoption gap for DApps. NEAR  has raised $12.1 million from a hedge fund, Metastable Capital, and the venture firm Accomplice. Read more

Node: Node is the first AI-as-a-service platform that enables users of business applications to see into the future. Node has raised $16 million in new funding that brings its total capital raised to date to $36 million. Investors include Mark Cuban, Avalon Ventures, New Enterprise Associates, Will Smith's Dreamers Fund, JetBlue Technology Ventures, and others. Read more

Microphyt: Microphyt researches, develops, produces, and markets natural algae-based products that contribute to weight loss and to brain health. Microphyt has raised €28.5 million in funding co-led by Sofinnova Partners and BPI France. Read more